Merck Group Briefing Summary

Company Overview

Founded

1668

Over 350 years of innovation

Employees

62,000+

Global workforce

Countries

65

Global presence

R&D Investment

€2.3B

2024

Sales

€21.2B

2024

Merck KGaA, Darmstadt, Germany operates globally as a vibrant science and technology company. In the U.S. and Canada, we operate as:

EMD Serono in the Healthcare business
MilliporeSigma in the Life Science business
EMD Electronics in the high-tech materials business

Vision & Mission

"Sparking discovery, elevating humanity"

Our vision is more than just a statement; it's a promise to millions of customers, patients, and communities worldwide. It represents our unwavering commitment to drive innovations that make a deep impact on lives across the globe.

We advance science and technology, fostering innovation that opens new possibilities while enhancing quality of life, ensuring our advancements in Life Science, Healthcare, and Electronics benefit society.

Business Sectors Overview

Life Science

€8.9B

Net Sales 2024

Healthcare

€8.5B

Net Sales 2024

Electronics

€3.8B

Net Sales 2024

Life Science Business

Our tools, services and digital platforms make research simpler, more exact, and help to deliver breakthroughs more quickly, ensuring that tests are accurate and the medicines we take can be trusted.

Net Sales

€8.9B

Products

300,000+

Global Distribution Centers

63

Manufacturing & Testing Sites

50+

Global Customers

1.6M

Key Products & Solutions

Product Area	Description	Applications
Genome Editing	CRISPR technologies and tools	Gene therapy, research, disease modeling
Biologics	Manufacturing solutions for biopharmaceuticals	Monoclonal antibodies, vaccines, cell & gene therapies
Food & Beverage Testing	Pathogen detection solutions	Safety assurance, quality control, regulatory compliance
Lab Water	Purification systems	Research integrity, pharmaceutical manufacturing
BioProcessing	Single-use technologies	Flexible manufacturing, contamination prevention

Key Points for Healthcare Colleagues:

Life Science provides critical tools that enable healthcare innovations
Our CRISPR products support development of next-generation therapies
Single-use technologies revolutionize pharmaceutical manufacturing
Quality testing solutions ensure patient safety
Digital platforms accelerate drug discovery and development

Healthcare Business

"To help create, improve and prolong lives – as one for patients."

The Healthcare business sector focuses on specialty-focused therapeutic areas:

Oncology
Cardiovascular Metabolism and Endocrinology
Neurology & Immunology
Fertility

Net Sales

€8.5B

40% of Group sales

Patients Reached

93M+

annually worldwide

Fertility Success

6M+

babies worldwide

Key Achievements

25+ years in Multiple Sclerosis (MS) treatment with two approved medications in major global markets
Robust clinical development pipeline in oncology, neuroimmunology, autoimmune diseases, and global health challenges like malaria
Industry-leading fertility treatments that have helped over 6 million babies be born worldwide

Electronics Business

"Advancing digital living"

Our product and service portfolio enables the future of electronics in our data-driven world. Our science sits inside technologies that are changing the way we create, access, store, process and display information.

Net Sales

€3.8B

Semiconductor Solutions

69%

of Electronics sales

Asia-Pacific Sales

68%

regional concentration

Key Products & Applications

Product Area	Description	End Applications
Semiconductor Materials	Advanced chemicals for chip manufacturing	Smartphones, computers, automotive electronics
OLED Technology	Organic light-emitting diode materials	Displays, TVs, smartphones, lighting
Liquid Crystal Technologies	Advanced display solutions	Screens, monitors, automotive displays
Smart Systems	Integrated solutions for connectivity	IoT devices, smart cities, connected vehicles
Future Mobility	Materials for next-gen transportation	Electric vehicles, autonomous driving systems

Key Points for Healthcare Colleagues:

Our semiconductor materials make smartphones faster and smarter
OLED and liquid crystal technologies make displayed images sharper
Electronics materials enable medical devices, diagnostic equipment, and digital health solutions
Materials science supports advancements in remote patient monitoring and telehealth
Smart systems from Electronics division contribute to modern healthcare infrastructure

Sustainability Strategy

SUSTAINABILITY is a KEY PRIORITY of our Group strategy

Social Impact

By 2030, we will help over 1 billion people through sustainable science and technology

Value Chain

By 2030, we will fully integrate sustainability into our value chain

Climate Action

By 2040, we will achieve climate neutrality and reduce resource consumption

Merck's sustainability initiatives focus on these key UN Sustainable Development Goals:

Good Health and Well-being
Responsible Consumption
Reduced Inequalities
Climate Action
Industry Innovation

Executive Leadership Team

Role	Name
Executive Board Chair & Group CEO	Belén Garijo
Life Science CEO	Matthias Heinzel
Healthcare CEO	Peter Guenter
Electronics CEO	Kai Beckmann
Chief Financial Officer	Helene von Roeder
Chief People Officer	Khadija Ben Hammada

Key Takeaways

One Merck: Three complementary business sectors working together to advance science and technology
Long Heritage: Founded in 1668, combining centuries of experience with cutting-edge innovation
Global Impact: €21.2B company with operations in 65 countries and over 62,000 employees worldwide
Life Science: Enabling scientific discovery and biopharmaceutical manufacturing with over 300,000 products
Healthcare: Focused on specialty therapeutic areas with treatments serving 93+ million patients annually
Electronics: Powering the digital revolution with semiconductor and display technologies
Sustainability: Committed to climate neutrality by 2040 and benefiting 1+ billion people by 2030